🇺🇸 FDA

Intelligence · Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda — grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≤24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months — use filters for patent-cliff planning.

Page 15 of 30

  1. US 8895588

    Pyrazole compound

    Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8895591

    Tricyclic compound and pharmaceutical use thereof

    Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8884019

    Benzimidazole compound crystal

    Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8883788

    Fused heterocyclic ring compound

    Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8883818

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8871487

    Compositions, methods and uses for inducing viral growth

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8871766

    Heterocyclic compounds

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8871273

    Method for producing granules

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8865745

    Pyrazolone derivatives as PDE4 inhibitors

    Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8865717

    Heterocyclic compounds

    Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8865217

    Oral preparation comprising pioglitazone

    Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8853215

    Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8846088

    Melt granulation of a composition containing a calcium-containing compound

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8846101

    Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8846713

    Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8841333

    Methods for treating nephrolithiasis

    Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8841120

    Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

    Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8835420

    Azaindole derivatives

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8829189

    Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8829008

    Organic compounds

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8828429

    Release-control composition

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8822470

    Substituted pyrido[2,3-b]pyrazines

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8822699

    Heterocyclic compound and use thereof

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8821926

    Tablet containing hardly soluble active ingredient

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8816085

    Methylpyrrolopyridinecarboxamides

    Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8815801

    Controlled release composition and method of producing the same

    Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8808735

    Fast wet-massing method for the preparation of calcium-containing compositions

    Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8809542

    Salts of benzimidazole compound and use thereof

    Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8802695

    Apoptosis signal-regulating kinase 1 inhibitors

    Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8791107

    N-substituted oxazinopteridines and oxazinopteridinones

    Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8785491

    Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8785429

    Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8784885

    Controlled release preparation

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8785460

    Tricyclic compounds and use thereof

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8778934

    Heterocyclic compound and use thereof

    Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8778871

    Metastin derivatives and use thereof

    Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8778944

    Pyridazinone compounds

    Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8772277

    Nitrogen-containing heterocyclic compound

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8765176

    Method of manufacturing tablet

    Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8765909

    Metastin derivatives and use thereof

    Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8758817

    Dosage form containing (S)-pantoprazole as active ingredient

    Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8754218

    Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives

    Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8754108

    Freeze-dried pantoprazole preparation and pantoprazole injection

    Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8753646

    IPV-DPT vaccine

    Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8735401

    Thienopyrimidine compounds and use thereof

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8729102

    Bicyclic compound

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8722660

    Heterocyclic compound

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8722084

    Controlled release preparation

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.